Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 771 clinical trials
featured
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

The primary objectives of this study are to evaluate the safety and efficacy of filgotinib in the induction and maintenance treatment of moderately to severely active ulcerative colitis (UC) in

remission
tumor necrosis factor alpha
vedolizumab
immunomodulators
corticosteroids
  • 2042 views
  • 26 Apr, 2019
  • 1 location
featured
Ulcerative Colitis Research Study

Local doctors are looking for people with Ulcerative Colitis for clinical research studies of an investigational medication. Must be receiving treatment for Ulcerative Colitis

ulcerative colitis
  • 760 views
  • 07 Nov, 2020
  • 1 location
featured
DIABETICS WITH FOOT ULCERS

A DIABETIC FOOT ULCER IS AN OPEN SORE OR WOUND THAT OCCURS IN APPROXIMATELY 15 PERCENT OF PATIENTS WITH DIABETES AND IS COMMONLY LOCATED ON THE BOTTOM OF THE FOOT.  

  • 56 views
  • 11 Sep, 2019
  • 1 location
featured
Ulcerative Colitis (UC) Study at ClinSearch

Ulcerative Colitis (UC) is another form of inflammatory bowel disease (IBS). Unlike Crohn’s, which can affect any part of the digestive tract, UC only affects the colon and rectum.

inflammatory bowel disease
  • 15 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 2, Double-Blind, Dose-Ranging, Placebo-Controlled Study With Open-Label Extension to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis

This Phase 2 study is designed to evaluate the efficacy and safety of itacitinib in men and women with moderate to severe UC. The study consists of Part A and Part B, which consist of 12 weeks of double-blind, randomized, placebo-controlled treatment periods followed by 40 weeks open label extension …

adalimumab
infliximab
hematochezia
endoscopy
vedolizumab
  • 48 views
  • 23 Nov, 2020
  • 5 locations
featured
ECO-RESET: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults with Active Mild-to-Moderate Ulcerative Colitis

To demonstrate the efficacy of study drug, SER-287, to induce clinical remission in patients with active mild-to-moderate ulcerative colitis.  

remission
endoscopy
corticosteroids
tumor necrosis factor
  • 219 views
  • 23 Nov, 2020
  • 1 location
featured
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

  • 2075 views
  • 23 Nov, 2020
  • 22 locations
featured
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 52)

The purpose of this study is to determine whether etrasimod is a safe and effective treatment for moderately to severely active ulcerative colitis.

  • 44 views
  • 08 Dec, 2020
  • 1 location
featured
The effect of daily intake of two different doses of Bifidobacterium Breve Bif195 on small-intestinal damage induced by Acetlysalicylic Acid- a randomized, double-blind, placebo-controlled, three-armed, parallel group trial in healthy volunteers.

common causes of peptic ulcer bleeding in developed countries and is associated with a significant increased risk of upper gastrointestinal (GI) bleeding and ulcers.  Live bacteria formulated

  • 314 views
  • 23 Nov, 2020
  • 1 location
featured
A3921210 OVATION  

This study, A3921210 is designed to evaluate the efficacy, safety and pharmacokinetics (PK) of tofacitinib in pediatric participants with moderately to severely active UC. In the US patients with prior TNFi failure or intolerance will be enrolled. Outside of the US, TNFi naïve and TNFi experienced patients will be enrolled.All eligible participants …

remission
pediatric ulcerative colitis
hematochezia
sulfasalazine
mercaptopurine
  • 1 views
  • 23 Sep, 2021
  • 7 locations